Show simple item record

dc.contributor.authorMa, Yunsheng
dc.contributor.authorOckene, Ira S.
dc.contributor.authorRosal, Milagros C.
dc.contributor.authorMerriam, Philip A.
dc.contributor.authorOckene, Judith K.
dc.contributor.authorGandhi, Pritesh J.
dc.date2022-08-11T08:10:20.000
dc.date.accessioned2022-08-23T17:04:46Z
dc.date.available2022-08-23T17:04:46Z
dc.date.issued2010-06-21
dc.date.submitted2010-11-23
dc.identifier.citationYunsheng Ma, Ira S. Ockene, Milagros C. Rosal, Philip A. Merriam, Judith K. Ockene, and Pritesh J. Gandhi, “Randomized Trial of a Pharmacist-Delivered Intervention for Improving Lipid-Lowering Medication Adherence among Patients with Coronary Heart Disease,” Cholesterol, vol. 2010, Article ID 383281, 11 pages, 2010. doi:10.1155/2010/383281 <a href="http://dx.doi.org/10.1155/2010/383281">Link to article on publisher's website</a>
dc.identifier.doi10.1155/2010/383281
dc.identifier.urihttp://hdl.handle.net/20.500.14038/44707
dc.description.abstractA randomized trial of a pharmacist-delivered intervention (PI) versus usual care (UC) was conducted; 689 subjects with known coronary heart disease were recruited from cardiac catheterization laboratories. Participants in the PI condition received 5 pharmacist-delivered telephone counseling calls post-hospital discharge. At one year, 65% in the PI condition and 60% in the UC condition achieved an LDL-C level <100 mg/dL (P=.29); mean statin adherence was 0.88 in the PI, and 0.90 in the UC (P=.51). The highest percentage of those who reached the LDL-C goal were participants who used statins as opposed to those who did not use statins (67% versus 58%, P=.05). However, only 53% and 56% of the patients in the UC and PI conditions, respectively, were using statins. We conclude that a pharmacist-delivered intervention aimed only at improving patient adherence is unlikely to positively affect outcomes. Efforts must be oriented towards influencing physicians to increase statin prescription rates.
dc.language.isoen_US
dc.rightsCopyright © 2010 Yunsheng Ma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
dc.subjectCoronary Disease
dc.subjectIntervention Studies
dc.subjectPharmacists
dc.subjectPatient Compliance
dc.subjectMedication Adherence
dc.subjectHydroxymethylglutaryl-CoA Reductase Inhibitors
dc.subjectBehavioral Disciplines and Activities
dc.subjectBehavior and Behavior Mechanisms
dc.subjectCardiovascular Diseases
dc.subjectCommunity Health and Preventive Medicine
dc.subjectPreventive Medicine
dc.titleRandomized Trial of a Pharmacist-Delivered Intervention for Improving Lipid-Lowering Medication Adherence among Patients with Coronary Heart Disease
dc.typeJournal Article
dc.source.journaltitleCholesterol
dc.source.volume2010
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1124&amp;context=prevbeh_pp&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/prevbeh_pp/125
dc.identifier.contextkey1659012
refterms.dateFOA2022-08-23T17:04:47Z
html.description.abstract<p>A randomized trial of a pharmacist-delivered intervention (PI) versus usual care (UC) was conducted; 689 subjects with known coronary heart disease were recruited from cardiac catheterization laboratories. Participants in the PI condition received 5 pharmacist-delivered telephone counseling calls post-hospital discharge. At one year, 65% in the PI condition and 60% in the UC condition achieved an LDL-C level <100 mg/dL (P=.29); mean statin adherence was 0.88 in the PI, and 0.90 in the UC (P=.51). The highest percentage of those who reached the LDL-C goal were participants who used statins as opposed to those who did not use statins (67% versus 58%, P=.05). However, only 53% and 56% of the patients in the UC and PI conditions, respectively, were using statins. We conclude that a pharmacist-delivered intervention aimed only at improving patient adherence is unlikely to positively affect outcomes. Efforts must be oriented towards influencing physicians to increase statin prescription rates.</p>
dc.identifier.submissionpathprevbeh_pp/125
dc.contributor.departmentDepartment of Medicine, Division of Cardiovascular Medicine
dc.contributor.departmentDepartment of Medicine, Division of Preventive and Behavioral Medicine


Files in this item

Thumbnail
Name:
hindawi_cholesterol_383281.pdf
Size:
534.4Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record